Assessment of Echocardiography and Biomarkers for the Extended Prediction of Cardiotoxicity in Patients Treated With Anthracyclines, Taxanes, and Trastuzumab
Details
The content you want is available to Zendy users.Already have an account? Click here. to sign in.